March « 2016 « Science and Enterprise

Clinical Trial Advances Dengue Vaccine Candidate

By Alan, on March 17th, 2016%

(CDC.gov)

17 March 2016. A small-scale clinical trial testing an experimental vaccine with people given live dengue viruses shows the vaccine is effective in preventing dengue infections. The team from Johns Hopkins University and University of Vermont published its findings in yesterday’s (16 March) issue of Science Translational Medicine; paid subscription required.

The . . . → Read More: Clinical Trial Advances Dengue Vaccine Candidate

EKG Technology Integrated into Apple Watch Band

By Alan, on March 16th, 2016%

Apple Watch with Kardia Band and app (AliveCor Inc.)

16 March 2016. Owners of an Apple Watch will soon be able to track their heart rhythms, using electrocardiogram or EKG sensors built into the wrist band for the device. The Kardia Band and supporting Apple Watch app are made by AliveCor Inc. in . . . → Read More: EKG Technology Integrated into Apple Watch Band

Technique Speeds, Eases Bone Marrow Stem Cell Collection

By Alan, on March 16th, 2016%

Research team members, L-R, Chad Heazlewood, senior author Susan Nilsson, and first author Benjamin Cao (CSIRO)

16 March 2016. A lab in Australia developed a process that makes it easier and faster to harvest blood-forming stem cells for treating diseases such as leukemia. The team led by Susan Nilsson at Monash University in . . . → Read More: Technique Speeds, Eases Bone Marrow Stem Cell Collection

Roche Licensing Biotech Immunotherapies in $1B Deal

By Alan, on March 15th, 2016%

(PDPics/Pixabay)

15 March 2016. The biotechnology company Blueprint Medicines, a developer of cancer treatments based on a patient’s precise genomic make-up, is partnering with the pharmaceutical company Roche on cancer immunotherapies. The agreement gives Roche options to license up to 5 small-molecule, or low molecular-weight therapies, in a deal that could bring Blueprint . . . → Read More: Roche Licensing Biotech Immunotherapies in $1B Deal

Injected Drug Forms Anti-Cancer Nanoparticles in Tumors

By Alan, on March 15th, 2016%

Mauro Ferrari (Houston Methodist Research Institute)

15 March 2016. Medical researchers developed a drug delivery technique that in lab mice forms anti-cancer nanoparticles inside metastatic tumors, promising much more potent cancer treatments. The team led by Mauro Ferrari and Haifa Shen at Houston Methodist Research Institute in Texas published its findings in yesterday’s . . . → Read More: Injected Drug Forms Anti-Cancer Nanoparticles in Tumors

Beta Cell Patch Designed to Control Blood Glucose Levels

By Alan, on March 14th, 2016%

Zhen Gu (University of North Carolina, Chapel Hill)

14 March 2016. A patch device made of beta cells — the cells that produce insulin — was shown to produce insulin on demand in lab mice induced with diabetes. A team from the biomedical engineering department jointly hosted by University of North Carolina in . . . → Read More: Beta Cell Patch Designed to Control Blood Glucose Levels

Biomarker Profiles Shown to Improve Ovarian Cancer Survival

By Alan, on March 14th, 2016%

(National Heart, Lung, and Blood Institute, NIH)

14 March 2016. A clinical trial of people with ovarian cancer shows patients receiving treatments matching their particular molecular profiles survived an average of 9 months longer than those receiving one or more drugs not matching their biomarkers. Results of the study, conducted by Caris Life . . . → Read More: Biomarker Profiles Shown to Improve Ovarian Cancer Survival

Vibration Technology Developed to Diagnose Back Pain

By Alan, on March 11th, 2016%

(Michael Dorausch, Flickr)

11 March 2016. Researchers at University of Alberta adapted engineering technologies using vibrations to develop a new way to diagnose spinal problems causing back pain. The team led by Alberta physical therapy professor Greg Kawchuk reported results of tests comparing its technology to MRI in today’s (11 March) issue of . . . → Read More: Vibration Technology Developed to Diagnose Back Pain

FDA Gives Initial Clearance for Engineered Mosquitoes

By Alan, on March 11th, 2016%

Aedes aegypti mosquito biting a human (U.S. Department of Agriculture)

11 March 2016. The U.S. Food and Drug Administration issued a preliminary report that self-limiting engineered mosquitoes will have no significant environmental impacts on the Florida Keys, where they plan to be tested. The report agrees with an environmental assessment by Oxitec Ltd., . . . → Read More: FDA Gives Initial Clearance for Engineered Mosquitoes

Process Devised for Plastics from Carbon Dioxide, Plants

By Alan, on March 10th, 2016%

First author Aanindeeta Banerjee, left, and Matthew Kanan (Stanford University)

10 March 2016. Producing common plastics like polyester today often needs large inputs of fossil fuel derivatives. A chemistry lab at Stanford University in California developed a low-carbon alternative to polyester that combines recycled carbon dioxide with inedible plant matter, such as agricultural . . . → Read More: Process Devised for Plastics from Carbon Dioxide, Plants

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise